SENSIBLE-EXO: Improving Grasp Function in People With Sensorimotor Impairments by Combining Electrical Stimulation With a Robotic Hand Orthosis

Sponsor
Andrea Cimolato (Other)
Overall Status
Recruiting
CT.gov ID
NCT05976087
Collaborator
(none)
20
1
1
84
0.2

Study Details

Study Description

Brief Summary

Hand motor and sensory impairments resulting from neurological disorders or injuries affect more than 50 million individuals worldwide. Conditions such as stroke, spinal cord injury (SCI), and traumatic brain injury (TBI) can cause long-term hand impairments, greatly impacting daily activities and social integration. Since traditional physiotherapy has limited effectiveness in rehabilitation, assistive devices helping in performing in daily activities have emerged as a necessary solution. Soft exoskeletons offer advantages as they are more comfortable and adaptable for the user, but they often struggle to generate sufficient force. On the other hand, electrical stimulation garments, like e-sleeves, show promise by stimulating nerves and muscles in the forearm. However, achieving precise and stable movement control remains challenging due to difficulties in electrode placement for targeted stimulation. Furthermore, none of the currently available devices are capable of artificially restoring lost sensation in users' hands, limiting their ability to manipulate with fragile objects.

Recognizing these limitations, our study proposes a solution that combines a standard hand soft exoskeleton with: (i) electrical stimulation to the fingers' flexor and extensor muscles to generate artificial muscle contractions synchronized with the exoskeleton motion, compensating for the lack of gripping force, and (ii) electrical stimulation to the nerves to artificially restore the lost sensation of touch, enabling users to receive feedback on the force they are applying when interacting with the environment. The investigators refer to this proposed combination as Sensible-Exo.

To achieve this goal, our project aims to evaluate the functional improvements in assistive and rehabilitative scenarios using SensoExo in comparison to use only the exoskeleton or having no support at all. The exoskeleton will be coupled with an electrical stimulating sleeve capable of delivering non-invasive electrical stimulation in the form of Functional Electrical Stimulation (FES) and Transcutaneous Electrical Nerve Stimulation (TENS). A glove with embedded force and bending sensors will be used to modulate the electrical stimulation. Additionally, apart from studying the enhancement of functional tasks, the investigators will explore improvements in body perception, representation, and multi-sensory integration. Indeed, the investigators also aim at identifying the way patients perceive their body by means of ad-hoc virtual reality assessments that has been developed. Before each assessment patient will perform some predefined movement in virtual reality to familiarize with it and increase embodiment.

During the study, participants will perform a range of tasks based on their residual abilities, including motor tasks (e.g., grab and release, Toronto Rehabilitation Institute Hand Function Test, grip force regulation test, virtual egg test), cognitive tasks (dual tasks), and assessments of body representation and perception. Some of these tasks will be conducted in Virtual Reality environments, both with and without active stimulation.

Condition or Disease Intervention/Treatment Phase
  • Device: SensoExo
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
20 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Improving Grasp Function in People With Sensorimotor Impairments by Combining Electrical Stimulation With a Robotic Hand Orthosis
Actual Study Start Date :
Jul 1, 2023
Anticipated Primary Completion Date :
Jun 30, 2026
Anticipated Study Completion Date :
Jun 30, 2030

Arms and Interventions

Arm Intervention/Treatment
Experimental: Experimental group

Device: SensoExo
combination of sensory feedback and the use of soft exoskeleton

Outcome Measures

Primary Outcome Measures

  1. Change in Range of Motion with electrical stimulation and without no electrical stimulation [up to one month before; thorugh study completition (average 1 month); up to one month after]

    Range of motion will be measured and compared among conditions

  2. Change in the area with tactile feedback in the hand with electrical stimulation and with no electrical stimulation [up to one month before; thorugh study completition (average 1 month); up to one month after]

    Semmes-Weinstein Monofilament Test will be used to assess the residual tactile feedback

  3. Change in functional tasks performance with sensory feedback and without sensory feedback quantified by the number of successful grasp and release tasks [up to one month before; thorugh study completition (average 1 month); up to one month after]

    Number of successful transportation of objects over an obstacle

  4. Change between functional tasks with sensory feedback and with no sensory feedback in number of virtual egg successful grasping [up to one month before; thorugh study completition (average 1 month); up to one month after]

    Number of successful transportations of fragile objects over an obstacle

  5. Change between functional tasks with sensory feedback and with no sensory feedback in grasping force [up to one month before; thorugh study completition (average 1 month); up to one month after]

    Grasping forces will be assessed during functional performance of the subjects

  6. Change between tasks with sensory feedback and with no sensory feedback in arm joints kinemtics [up to one month before; thorugh study completition (average 1 month); up to one month after]

    Joint kinematics measurements will be measured with motion capture systems during functional performance of the subjects

Secondary Outcome Measures

  1. Change in experienced physical, mental, and social effects [up one week before first session and up one week after last session]

    Neuro-QuL measurement system will be as assessment tool

  2. Change in Proprioceptive drift between different conditions [up one week before first session and up one week after last session]

    To measure embodiment subjects will be asked after VR sessions to indicate where they feel their arm without looking at the limb in real world. This is a measure of embodiment.

  3. Change in Telescoping measures between different conditions [up one week before first session and up one week after last session]

    To measure embodiment subjects will be asked after VR sessions to indicate how long they feel their arm without looking at the limb in real world. This is a measure of embodiment.

  4. Change from baseline performance between tasks accomplished with sensory feedback and with no sensory feedback in Embodiment [up one week before first session and up one week after last session]

    Embodiment will be measured with questionnaires (from -3 to +3, +3 totally agrees; two questions are from 1 to 10 (to measure vividness, where 10 is max vividness) and from 1 to 100 (to measure prevalence, where 100 is max duration of the embodiment feeling))

  5. Measures of self-body representation [up one week before first session; thorugh study completition (average 1 month); up one week after last session]

    This will be measured in virtual reality by means of ad-hoc Body Landmark test. This is a body representation measurements.

  6. Measures of body-space representation [up one week before first session; thorugh study completition (average 1 month); up one week after last session]

    This will be measured in virtual reality by means of ad-hoc Hand Peri personal Space test. This is a body representation measurements.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Impairment of the motor and sensory functions of the hand in chronic stage

  • The subject should have good proximal arm function (i.e. good shoulder abduction and elevation)

Exclusion Criteria:
  • Cognitive and communication deficits impairment

  • Prior or current psychological diseases such as borderline, schizophrenia, Depression or Maniac Depression

  • Major comprehension and memory deficits

  • Pregnancy

  • Epilepsy

  • Pacemaker

  • Cybersickness

Contacts and Locations

Locations

Site City State Country Postal Code
1 Neuroengineering Lab Zürich Zurich Switzerland 8001

Sponsors and Collaborators

  • Andrea Cimolato

Investigators

  • Principal Investigator: Stanisa Raspopovic, PhD, ETH Zurich

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Andrea Cimolato, Study coordinator, ETH Zurich
ClinicalTrials.gov Identifier:
NCT05976087
Other Study ID Numbers:
  • 1-010428
First Posted:
Aug 4, 2023
Last Update Posted:
Aug 4, 2023
Last Verified:
Jul 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Andrea Cimolato, Study coordinator, ETH Zurich
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 4, 2023